








     
   
Original Article
EFFECT OF pH, SELECTED CYCLODEXTRINS AND COMPLEXATION METHODS ON THE
SOLUBILITY OF LORNOXICAM
SHRISHAILGOUDA S. PATIL1, V. RAM MOHAN GUPTA2, K. SRIKANTH GUPTA2, H. DODDAYYA1
1Department of Pharmaceutics, N. E. T Pharmacy College, Raichur, Karnataka, India, 2Department of Pharmaceutics, Pulla Reddy Institute
of Pharmacy, Hyderabad, Andhra Pradesh, India.
Email: shailpharma@gmail.com
Received: 02 Jun 2014 Revised and Accepted: 27 Jul 2014
 
ABSTRACT 
Objective: The objective of the present study is to investigate the effect of pH, selected cyclodextrins and methods of complexation on the solubility 
of lornoxicam.  
Methods: Phase solubility studies were carried out according to Higuchi and Connors. Inclusion complexes of lornoxicam were prepared by 
different methods like kneading, ultrasoncation, spray drying along with the physical mixtures using β cyclodextrin and hydroxypropyl β 
cyclodextrins.  
Results: Lornoxicam being weakly acidic drug showed extremely low solubility in the acidic medium (pH 1.2) and poor solubility in water. The 
solubility of the drug increased as the pH of the medium was subsequently increased up to 7.4 and a drastic increase in solubility perhaps several 
hundred folds was observed with the alkaline phosphate buffer (pH 10.0). Phase solubility studies revealed that, hydroxypropyl β cyclodextrin (HP 
β CD) up to the concentration of 20 mM showed a linear increase in solubility of lornoxicam whereas the solubility of lornoxicam was increased up 
to β cyclodextrin (β CD) concentration of 14 mM and beyond that the solubility of the drug reduced probably due to precipitation of the complexes. 
The stability constant (Ks) was found to be 378.55 M-1 and 867.262 M-1
Conclusion: The study demonstrated the distinctive pH dependent of solubility of lornoxicam and also showed that cyclodextrins especially HP β 
CD can be utilized to improve the solubility of lornoxicam.  
 for β CD and HP β CD respectively. Inclusion complexes of lornoxicam with 
cyclodextrins were prepared employing different methods and the effect of complexation methods on the dissolution of lornoxicam was studied. 
Dissolution studies revealed that, irrespective of the cyclodextrins used (β CD and HP β CD), highest drug release rate was observed from the spray 
dried products compared to those prepared by kneading and ultrasonication methods. Inclusion complexes prepared using HP β CD showed higher 
drug release compared to those prepared using β CD.  
Keywords: Lornoxicam, pH, Solubility, Cyclodextrins, Complexation methods, Dissolution. 
 
INTRODUCTION  
Combinatorial chemistry and high throughput screening seem to 
have led to an increase in the number of poorly water-soluble drug 
candidates coming out from the discovery pipeline [1]. More than 
90% of drugs approved since 1995 have poor solubility, poor 
permeability, or both [2]. Many compounds currently under 
development are Biopharmaceutical Classification System Class II 
compounds, i. e., high permeability but poor solubility [3]. Poor 
aqueous solubility hinders the in vivo efficacy of the drugs due to 
low bioavailability, abnormal pharmacokinetic profile, inter-subject, 
inter-species variation [4] and thus pose challenging problems in the 
oral formulation development process.  
Lornoxicam, a congener of tenoxicam, is a new NSAID belonging to 
the oxicam group with extremely potent anti-inflammatory and 
analgesic activities. It is widely used for the symptomatic treatment 
of pain and inflammation in patients with rheumatoid arthritis and 
osteoarthritis. Lornoxicam (LRN) also showed great efficacy in 
various clinical trials in the management of perioperative and 
postoperative pain associated with gynecological, orthopedic, 
abdominal, and dental surgeries [5-8]. However, the drug is having 
very low aqueous solubility [9] resulting in dissolution rate limited 
absorption and thus limits its therapeutic efficacy due to hindered 
rate of absorption thereby delaying the onset of action. 
Enhancement in the solubility and the dissolution rate of such drugs 
can improve the oral bioavailability, which further improves the 
therapeutic efficacy and patient compliance. Different techniques 
have been used to improve the solubility/ dissolution rate of poorly 
soluble drugs and in middle of the alternatives, the use of 
cyclodextrin complexation presented a great interest [10]. In recent 
years, pharmaceutical applications of cyclodextrins (CDs) as 
additives and drug-complexing agents have been growing rapidly. 
CDs are cyclic oligosaccharides composed of glucopyranose units 
and can be represented as a truncated cone structure with a 
hydrophobic cavity. The hydrophobic cavity forms inclusion 
complexes with a wide range of guest molecules. Inclusion complex 
formation will modify physico-chemical properties such as solubility, 
stability and bioavailability of poorly water-soluble drugs [11]. 
It is also a well known fact that, the pH of the medium is one of the 
important factors affecting the solubility of drugs [12] especially the 
weakly acidic or basic drugs. Hence, the present study is undertaken 
taken with an aim to investigate the effect of pH, selected 
cyclodextrins and methods of complexation on the solubility of a 
novel NSAID, lornoxicam. The solubility study is carried out in 
different media (pH 1.2 to pH 10) to identify the physiological pH 
where the drug is having highest solubility and also the influence of 
selected cyclodextrins (β cyclodextrin and Hydroxpropyl β 
cyclodextrin) and methods of complexation in enhancing the 
solubility of lornoxicam was studied. 
MATERIALS AND METHODS 
Lornoxicam was obtained as gift sample from Sun Pharma Ltd., 
Vadodhara. β cyclodextrin and Hydroxpropyl β cyclodextrin were 
generously supplied by M/s Gangawal Chemicals, Mumbai. All other 
reagents used were of analytical grade and were purchased from Sd 
fine chemicals, Mumbai. 
Solubility Studies [13-15] 
Phase solubility studies were carried out according to the method 
reported by Higuchi and Connors. An excess amount of LRN was 
added to stoppered glass vials containing 10 ml aqueous solutions of 
varying concentrations of β cyclodextrin and Hydroxpropyl β 
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cyclodextrin (0-20 mM) and the suspensions were stirred for 24 h at 
37±0.5ºC using temperature controlled water bath (Remi Motors, 
Mumbai). After equilibrium, the samples were filtered and 
absorbance was recorded at 376.5 nm using UV/Vis 
spectrophotometer (Shimadzu UV-1700).  
Phase solubility diagrams were obtained by plotting the molar 
concentration of solubilized lornoxicam versus the molar 
concentrations of the CDs used. The apparent stability constants 
(Ks) were estimated from the straight line of the phase solubility 
diagrams according to the following equation:  
Ks = Slope/So (1- Slope) 
Where, So is the solubility of l lornoxicam in absence of 
cyclodextrins. 
In order to know the effect of pH on solubility of LRN, analogous 
solubility studies in different media (pH 1.2 - pH 10.0) were also 
carried out under same experimental conditions. The solubility of 
LRN in each buffer media was assessed using UV/Vis 
spectrophotometer at 372.5 nm for acidic media and 377.5 nm for 
all other media studied.  
Preparation of inclusion complexes 
With an aim to improve the solubility of LRN, inclusion complexes 
with β CD and HP β CD were prepared at two molar ratios (1:1 and 
1:2) by kneading, ultrasonication and spray drying methods. 
Physical mixtures of LRN and CDs in the same molar ratios were also 
prepared for comparison purpose. 
Physical mixture 
The physical mixtures were prepared by gently mixing the 
accurately weighed amounts of LRN and CDs in a glass mortar over a 
period of 30 minutes. 
Kneading method [16] 
The required quantities of LRN and CDs were accurately weighed, 
transferred to a glass mortar and thoroughly mixed. The above 
mixture was triturated with small volume of solvent blend of alcohol 
and water (1:1 ratio). The slurry obtained was kneaded for 30 
minutes and then dried at 37ºC for 48 hrs in hot air oven (Servewell 
Instruments and Equipments Pvt, Bangalore, India). The dried mass 
was pulverized and passed through sieve # 100 and stored in 
desiccator over fused calcium chloride for further use. 
Ultrasonication [17] 
The slurry of LRN and CDs was prepared as mentioned in the 
kneading method and it was ultrasonicated for 6h. During 
ultrasonication, paste like consistency was maintained using 
alcohol-water (1:1 ratio). After ultrasonication, the slurry was dried 
at 37ºC for 48 hrs in hot air oven. The dried mass was pulverized 
and passed through sieve # 100 and stored in desiccator over fused 
calcium chloride for further use. 
Spray drying [10] 
Spray dried product was obtained by dissolving required quantities 
of CDs and LRN in 100 ml of alcohol and water (1:1) and thereafter 
the solution was stirred vigorously using a magnetic stirrer for 24 
hrs. Subsequently spray drying of solution was carried out using 
laboratory scale spray drier (Lab Ultima- LU 222 advanced) under 
the following conditions: Inlet temperature 135 ºC, outlet 
temperature 60 ºC, feed rate 5 ml/min, air flow rate 500 cm3/h, 
automization air pressure at 2.5kg/cm2
Characterization of complexes 
 and aspiration set at 100%. 
The spray dried product thus obtained was collected, packed 
suitably and stored in a desiccator for further use. 
Drug content[16,18,] 
The percentage drug content was determined by taking each 
physical mixture and inclusion complexes equivalent to 10mg of 
lornoxicam in a 100 ml volumetric flask containing 50 ml of 
azeotropic mixture of water and methanol (60:40v/v) and the 
volume was made up to 100 ml using the same media and stirred for 
1hr using water bath shaker. The resulting solution was filtered and 
diluted appropriately with phosphate buffer of pH 7.4 and the 
absorbance was noted at 377.5 nm using UV/Vis spectrophotometer. 
Infrared spectroscopy 
The FT-IR spectra of pure drug, pure CDs, physical mixtures and the 
inclusion complexes were recorded on Shimadzu FT-IR 
spectrophotometer (IR Affinity 1) using KBr disk technique. The FT-
IR measurements were performed in the scanning range of 4000-
500 cm-1
In vitro dissolution 
. 
The dissolution studies for the pure drug, physical mixtures and 
inclusion complexes were carried out using USP dissolution 
apparatus (Type II) employing 0.1 N HCl as dissolution medium. The 
dissolution medium (900 ml) was stirred at 100rpm and the 
temperature was maintained at 37±0.5ºC. At specific time intervals 
aliquots were withdrawn, filtered through Whatman filter paper and 
suitably diluted and analyzed spectrophotometrically at 372.5 nm 
using the same media as blank. 
Statistical analysis 
The data obtained from the study was statistically analyzed by one 
way ANOVA (Tukey’s multiple comparison test) using GraphPad 
Prism Software-5.03 (Trial version, Graph Pad Software, San Diego, CA). 
The analysis was performed to know the statistical significance of pH, 
cyclodextrins and complexation methods on the solubility of LRN.  
RESULTS AND DISCUSSION 
Phase solubility Studies 
The phase solubility curve of lornoxicam in the presence of β CD and 
HP β CD is showed in Fig 1. From the figure it can be observed that β 
CD showed BS type solubility curve indicating limited solubility. The 
solubility of lornoxicam increased at the β CD concentration of 2-14 
mM and above this, the solubility decreased probably due to 
precipitation of the complexes. It has been reported that, β CD shows 
B type of curves due to poor solubility of ligand itself. However, HP β 
CD showed AL type curve as the solubility of lornoxicam  
linearly increased with increased concentration of HP β CD without 
undergoing any precipitation [13, 14, 19]. The slopes were found to 
be 0.0305 (β CD) and 0.0732 (HP β CD) which are less than 1 
indicating that a complex of 1:1 molar ratio was formed in the 
solution for both β CD and HP β CD. 
The stability constant (Ks) was found to be 378.55 M-1 and 867.262 
M-1 for β CD and HP β CD respectively. The correlation coefficient 
(r2) values observed from the phase solubility diagrams are 0.8880 
and 0.9824 for β CD and HP β CD respectively. The Ks values more 
than 100 and the high r2
 
 values indicate the formation of 
instantaneous and high order inclusion complexes between the 
lornoxicam and the CDs, especially HP β CD. 
 
 Fig. 1: Phase solubility curves of LRN in water 
 
Solubility of lornoxicam in different media 
The solubility of a weakly acidic or basic drug is often pH dependent. 
The solubility of LRN as a function of pH was carried out in triplicate 
Patil et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 8, 324-327 
 
326 
and is depicted in Fig 2. LRN being a weakly acidic drug with pKa 
value of 5.516 showed lowest solubility in the acidic medium and 
poor solubility in water. The solubility of the drug increased as the 
pH of the medium was subsequently increased up to 7.4 and a 
drastic increase in solubility perhaps several folds was observed 
with the alkaline phosphate buffer (pH 10). The pH dependent 
solubility could be due to existence of LRN molecules in uncharged 
form at lower pH media whereas at higher pH range, lornoxicam 
molecules are negatively charged thus showing the increased 
solubility [16]. 
 
 Fig. 2: Solubility of Lornoxicam in different media 
 
FT-IR studies 
In the present study, FT-IR technique is used to assess the formation 
of inclusion complexes that arises due to the interaction between the 
cyclodextrins and the drug. FT-IR spectra of pure drug lornoxicam, 
its physical mixture with β CD and HP β CD, the inclusion complexes 
prepared by different methods is given in Fig 3. The pure drug 
lornoxicam exhibited its characteristic absorption bands at 3099.61 
cm-1 due to aromatic C-H stretching and at 2926.01 cm-1 due to C-H 
stretching of CH3 group. The other prominent absorption bands 
appeared at 1647.21 cm-1 due to stretching vibrations of C=O of 
CONH, 1618.28 due to aromatic C=C and C=N stretching. Bending 
vibrations of NH group in the secondary amine were observed at 
1593.20 and 1544.96 cm-1 whereas aromatic C=C skeleton stretching 
vibrations were observed at 1500.62 cm-1. The peaks at 1423.47 cm-
1 and 1327.03 cm-1 corresponds to O=S=O group, 790 cm-1 due to 
substituted aromatic rings, 765.74 cm-1 
 
due to C-Cl stretching 
vibrations. The FT-IR spectra of physical mixtures of drug and 
cyclodextrins revealed no significant changes in absorption bands. 
However, the IR spectra of inclusion complexes prepared by 
different methods revealed that the major peaks corresponding to 
the LRN were affected. The changes in the characteristic bands of the 
drug confirm the formation of inclusion complex with both the 
cyclodextrins used. Thus, from the IR studies it can be concluded 
that the aromatic functional groups of the drug could have 
interacted with OH groups of the cyclodextrins through hydrogen 
bonding thereby forming the inclusion complexes.  
Fig. 3: FT-IR Spectra of Pure drug, Physical mixtures and 
inclusion complexes 
Drug content 
The drug content was found to be high in all the inclusion complexes 
prepared and it ranged from 87.38 (±1.78) to 97.94 (±1.30). The 
drug content was slightly reduced in case of complexes prepared 
with higher drug: cyclodextrin ratio irrespective of the cyclodextrin 
used.  
Dissolution study 
Dissolution rate profile for the pure drug, physical mixture and the 
inclusion complexes prepared by different methods utilizing β CD 
and HP β CD is given in Fig 4 and 5 respectively. Only about 15% of 
pure drug LRN was released in the acidic media (0.1N HCl) at the 
end of 90 min dissolution study. Slightly higher dissolution profiles 
of LRN were obtained from the physical mixtures and the kneaded 
products. Rapid dissolution is the characteristic feature of the 
inclusion complexes and indeed, significantly higher dissolution of 
LRN was observed for the inclusion complexes prepared from 
ultrasonication and spray drying methods compared to physical 
mixtures and kneaded products which is an indicative for the 
efficient complexation by the former methods. Among all the 
methods, highest dissolution was obtained for the spray dried 
products irrespective of the cyclodextrin utilized.  
As spray drying is an energy intensive process, rapid solvent 
evaporation leads to amorphization of the drug as very less time is 
offered for crystal building process along with the inclusion of drug 
in cavity of the cyclodextrin and thus resulting in higher solubility13
 
 
compared to other methods. In between the two cyclodextrins 
studied namely β CD and HP β CD, higher dissolution rates were 
obtained for both physical mixtures and inclusion complexes 
prepared from HP β CD. The higher dissolution of LRN from HP β CD 
complexes is also well supported by the phase solubility studies. 
From the dissolution studies it can be concluded that, HP β CD is 
better than β CD in enhancing the solubility and dissolution of 
lornoxicam. 




Fig. 5: Effect of complexation methods on release of LRN from 
HP BCD complexes 
Patil et al. 




Overall, from the study it is concluded that, the solubility of 
lornoxicam was highly dependent on the pH of the medium as well 
the cyclodextrins. Solubility was found to be lowest in acidic 
medium which increased progressively with increase in pH of the 
media and a drastic increase in solubility was observed in alkaline 
media (pH 10.0). Phase solubility studies revealed that, presence of 
HP β CD can efficiently increase the solubility of LRN than the β CD 
with the same molar concentrations used. From the dissolution 
studies it is concluded that, irrespective of the cyclodextrin used, 
highest release rate was obtained from the spray dried products 
compared to the inclusion complexes obtained from other methods. 
Among the two cyclodextrins, inclusion complexes prepared with HP 
β CD showed higher dissolution rates compared to β CD. Overall, 
from the study it is clear that, solubility and dissolution of 
lornoxicam is highly dependent on the pH of the medium, type of 
cyclodextrin and also the method of preparation of inclusion 
complexes. 
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